4.5 Article

Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer

Related references

Note: Only part of the references are listed.
Letter Critical Care Medicine

Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients

Arata Azuma et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study

Shoji Kudoh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

Acute exacerbations of idiopathic pulmonary fibrosis

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Medicine, General & Internal

Erlotinib in previously treated non-small-cell lung cancer

FA Shepherd et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)